SpeedySwab™ Rapid Antigen Self-Test, COVID-19 + Flu A&B, 2 Tests/Box

Fast, Reliable At-Home Testing for COVID-19 & Flu

The SpeedySwab™ Rapid COVID-19 + Flu A&B Antigen Self-Test is a simple and convenient at-home test designed to quickly and accurately differentiate between COVID-19 and influenza A & B. This test provides rapid results in just 15 minutes, helping individuals make informed health decisions.

Key Features:

Dual Detection: Differentiates between COVID-19, Flu A, and Flu B with a single test.

Fast & Reliable: Results in just 15 minutes for quick action.

Easy-to-Use: Simple anterior nasal swab collection, with self-collection for ages 14+ and adult-assisted collection for ages 2+.

At-Home Convenience: No prescription or lab visit required.

Up to 18-Month Shelf Life: Ensures availability when needed.

Who Can Use the SpeedySwab™ Self-Test?

Individuals aged two and older with symptoms of a respiratory infection consistent with COVID-19 or the flu.

• Ages 14+ can self-collect their sample.

• Ages 2+ require an adult to collect the sample.

This test is authorized for non-prescription home use in individuals with COVID-19 symptoms that began within the last 5 days. For the most accurate results, test twice over three days, with at least 48 hours between tests.

More Information About the SpeedySwab™ Test

• How does the SpeedySwab™ Rapid COVID-19 + Flu A&B Test work?

  SpeedySwab™ is a lateral flow antigen test that detects and differentiates COVID-19, Influenza A, and Influenza B proteins using a simple nasal swab sample. The test provides results in just 15 minutes.

• Who can use this test?

  This test is authorized for:

  • Individuals aged 14+ who can self-collect their nasal swab.

  • Children ages 2-13, with an adult collecting the sample.

  • Individuals experiencing symptoms of respiratory infection consistent with COVID-19 or the flu, within the first five (5) days of symptom onset.

  Physicians may also consider individuals with a family history of lung cancer or elevated risk due to environmental exposure and other risk-factors. LEAP can serve as a decision aid for individuals putting off lung cancer screening due to concerns about radiation exposure and the need for repeat scans over time.

  The referring physician should judge a patient’s risk in light of clinical factors following conversations with the patient. LEAP is not for those already diagnosed with lung cancer or currently undergoing treatment for lung cancer.

• How accurate is the test?

  The test has been clinically validated with the following sensitivity rates:

  • COVID-19: 92.6%

  • Flu A: 82.9%

  • Flu B: 90%

• How do I interpret the test results?

  The test device includes three separate result lines:

  • COVID-19 (SARS-CoV-2) Line

  • Influenza A Line

  • Influenza B Line
    A control line ensures that the test was performed correctly. Instructions on result interpretation are included in the test kit.

• How often should I test?

  For the most accurate results, it is recommended to test at least twice over three days, with at least 48 hours between tests.

• Is the SpeedySwab™ test FDA authorized?

  Yes, the test has received Emergency Use Authorization (EUA #EUA240014) from the U.S. FDA.

• Is the SpeedySwab™ test available in bulk for healthcare providers or organizations?

  Yes, the SpeedySwab™ Rapid COVID-19 + Flu A&B Test is available in a 25-test pack, designed for use by healthcare providers and organizations that need multiple tests. Learn more ⟩⟩

Downloadable Resources